I-131 MIBG therapy: Working to eliminate pediatric cancer

This study administers high doses of I-131 MIBG to children with relapsed or refractory neuroblastoma. Up to three treatments may be given.

This trial utilizes lower doses of I-131 MIBG, combined with immunotherapy, to treat children with relapsed or refractory neuroblastoma. The immunotherapy consists of an antibody that attaches to neuroblastoma cells and a drug that helps your child’s immune system work better.

A phase 2 trial that combines I-131 MIBG with vorinostat to treat children with relapsed or refractory neuroblastoma. This combination resulted in a better response rate than I-131 MIBG given alone, in a prior study.

Your child needs toys and activities to stay busy in the days after treatment. Pack items that can be thrown away after treatment, such as:

• Coloring books and crayons

• Card games 

• Inexpensive toys 

The room in which your child will stay has an audiovisual system so they can watch television and movies. We can also provide an electronic tablet that your child can use during their stay. Remember to bring any guides or information you received about your child’s care and safety.

After your child settles into the hospital room, their care team begins preparing for the infusion.

Your child might need a Foley catheter to collect urine. This is a small, flexible tube that a nurse places into the bladder. Although this is a simple and fast procedure, we typically have the catheter inserted while your child is heavily sedated to ensure there is minimal discomfort. 

When your child’s care team is ready to begin treatment, a nuclear medicine technologist brings a syringe of I-131 MIBG into the room on a cart with a lead shield.

The doctor gives the I-131 MIBG to your child through an IV. The infusion takes about 90 minutes. You and the care team monitor your child during and after the infusion.

Our program is designed to minimize contact with your child after treatment, while still keeping them happy and safe. This reduces radiation exposure to you and health care providers. 

You can expect your child to be in the hospital for two to five days. During this time:

• Your child’s body expels radiation through their urine.

• Your child can eat, play games, read, draw, etc.

• You help care for your child by providing comfort and performing tasks like bringing in meals, helping with toileting needs, etc.  You will be taught how to safely provide care while inside the I-131 MIBG room.

• You will spend much of your time in a sleep room located right next to the 1-131 MIBG room.

• From the sleep room you can talk with, and see your child, utilizing our closed-circuit AV system.

• Your child can leave the hospital when the radiation is at a safe level.

Once you return home, you need to continue to take precautions to protect others from low levels of radiation. This should continue for a few weeks or until your child’s doctor says your child’s radiation levels are safe. Our radiation safety team will provide specific guidelines for you before your child is discharged from the hospital.

The care team monitors your child’s health and blood counts for several weeks after treatment. Scans are usually done around six weeks after the I-131 MIBG infusion to assess your child's response to the treatment.

If your child’s doctor recommends I-131 MIBG therapy, you will meet with the care team to discuss the treatment. You can ask questions of the radiotherapy doctor, nurse practitioner, social worker and other team members. Together they will:

• Review your child’s cancer history

• Talk about radiation safety

• Talk about the treatment

• Discuss a plan to keep your child comfortable and engaged during their hospital stay

• Obtain consent to proceed with I-131 MIBG therapy